PHARMACOKINETICS (PK) OF HZN-825, A SMALL MOLECULE SELECTIVE ANTAGONIST OF LPAR1, AND THE EFFECT OF FOOD IN HEALTHY ADULT SUBJECTS

被引：0

作者：

Song, Y. ^{[1
]}

Ali, F. ^{[2
]}

Ye, Z. ^{[2
]}

Zarzoso, J. ^{[1
]}

Rogowski, J. ^{[1
]}

Sun, Y. ^{[1
]}

Xin, Y. ^{[1
]}

机构：

[1] Horizon Therapeut, San Francisco, CA USA

[2] Horizon Therapeut, Chicago, IL USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2023年 / 113卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

PII-071

引用

页码：S66 / S67

页数：2

共 50 条

[41] Effect of Food on the Pharmacokinetics of Tenofovir Amibufenamide: A Phase I, Randomized, Open-Label, Two-Period Crossover Trial in Healthy Adult Subjects
Liu, Jian
Wu, Minglan
Kai, Jiejing
Lin, Meihua
Zheng, Yunliang
Jiang, Yiya
Huang, Qian
Zhai, You
Qiu, Yunqing
DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 3061 - 3072
[42] PHARMACOKINETICS OF ELECLAZINE, A HIGHLY SELECTIVE INHIBITOR OF CARDIAC LATE NA plus CURRENT: EVALUATION OF SINGLE AND MULTIPLE-DOSE PK, AND FOOD EFFECT, IN HEALTHY VOLUNTEERS.
Begley, R.
Zhang, H.
Hellawell, J.
Wang, L.
Weston, J.
Ling, J.
Kearney, B. P.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S56 - S57
[43] A Phase 1, Open-Label Study to Evaluate the Effect of Food and Concomitant Itraconazole Administration on the Pharmacokinetics of AMG 986 in Healthy Subjects
Trivedi, Ashit
Mather, Omar
Vega, Silvia
Hutton, Shauna
Hellawell, Jennifer
Lee, Edward
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (07): : 849 - 856
[44] A phase 1, randomized study to evaluate safety, tolerability, and pharmacokinetics of GDC-3280, a potential novel anti-fibrotic small molecule, in healthy subjects
Cheung, Dorothy
Fong, Alice
Ding, Han Ting
Cabanski, Christopher R.
Wang, Jianshuang
Chen, Yuan
Bush, Jim
Harris, Jeffrey M.
Pan, Lin
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2021, 69
[45] EFFECT OF AGE AND ADMINISTRATION WITH FOOD ON THE SINGLE-DOSE PHARMACOKINETICS OF HT-3951, A SELECTIVE AND REVERSIBLE INHIBITOR OF MAO-B, IN NORMAL HEALTHY SUBJECTS
Carpenter, D. J.
Anderson, J. J.
Dewitt, T.
Djan, J.
Mason, C.
Parsons, J.
Ruckle, J.
Perera, P.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S35 - S35
[46] Evaluation of the Effect of Food and Age on the Pharmacokinetics of Oral Netupitant and Palonosetron in Healthy Subjects: A Randomized, Open-Label, Crossover Phase 1 Study
Calcagnile, Selma
Lanzarotti, Corinna
Gutacker, Michaela
Jakob-Rodamer, Verena
Kammerer, Klaus Peter
Timmer, Wolfgang
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2015, 4 (05): : 377 - 386
[47] A Phase 1 Randomized Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Escalating Oral Doses of Dordaviprone and the Effects of Food on the Bioavailability of Dordaviprone in Healthy Adult Subjects
Faison, Shamia L.
Batonga, Joelle
Arumugham, Thangam
Bartkus, Angela
Morrison, Marion
Mullin, Mark J.
Tippin, Tim
Naderer, Odin
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2025,
[48] Effect of casopitant, a novel NK-1 receptor antagonist, on the steady-state pharmacokinetics of the P-glycoprotein probe substrate, digoxin, in healthy subjects
Adams, Laurel
Johnson, Brendan
Yue, Lin
Zhang, Ke
Morrison, Royce
Lebowitz, Peter
CANCER RESEARCH, 2009, 69
[49] Safety, tolerability, and pharmacokinetics of BIBN4096BS, the first selective small molecule calcitonin gene-related peptide receptor antagonist, following single intravenous administration in healthy volunteers
Iovino, M
Feifel, U
Yong, CL
Wolters, JM
Wallenstein, G
CEPHALALGIA, 2003, 23 (07) : 689 - 689
[50] Safety, tolerability and pharmacokinetics of BIBN4096BS, the first selective small molecule calcitonin gene-related peptide receptor antagonist, following single intravenous administration in healthy volunteers
Iovino, M
Feifel, U
Yong, CL
Wolters, JM
Wallenstein, G
CEPHALALGIA, 2004, 24 (08) : 645 - 656

← 1 2 3 4 5 →